Nanotechnology Now - Press Release: Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO

Home > Press > Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO

Abstract:
Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO as of July, 16 2007. Dr. Williams' vast experience and skills will be valuable as Platypus transitions from a start-up to a growth-phase company. Prior to joining Platypus, Dr. Williams served as Senior Vice President and was responsible for product development at Asuragen. Before joining Asuragen, he was Vice President and General Manager of Ambion Diagnostics where he was responsible for the successful commercialization of several FDA-regulated diagnostic products. In addition, Dr. Williams spent over 10 years at Roche Diagnostics where he held several senior level positions, and he was a Vice President at Roche Applied Science during the launch of the LightCycler and many new PCR-based products for life science and diagnostic markets. As a precursor to his time at Roche Applied Science, Dr. Williams was Director of Operations at Roche Molecular Systems and was responsible for the production of all Roche PCR products. Dr. Williams began his career in the bio/pharmaceutical industry at Promega Corporation where he spent six years as Director of Operations. Dr. Williams received both his BS and PhD degrees from the University of Wisconsin-Madison.

Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO

Madison, WI | Posted on July 17th, 2007

####

About Platypus Technologies, LLC
Platypus Technologies, LLC develops, produces and markets nanotechnologies for the analytic and life sciences. The Company offers a variety of nanostructured surfaces for use in research and is also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions. This technology fuses advances in nanoscale science, materials science, and molecular biology to provide advanced tools for use in proteomics, cell studies, environmental monitoring and in vitro diagnostics. The Company has 23 employees and is located in the Fitchburg Technology Campus.

For more information, please click here

Contacts:
Dr. Minnie Gupta
Director of Marketing
Ph: 608.237.1270

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:

Related News Press

Announcements

Nanotube fiber antennas as capable as copper: Rice University researchers show their flexible fibers work well but weigh much less October 23rd, 2017

Arrowhead Presents Promising Preclinical Data on Development of ARO-AAT for Treatment of Alpha-1 Liver Disease at Liver Meeting(R) 2017 October 23rd, 2017

A step closer to understanding quantum mechanics: Swansea University�s physicists develop a new quantum simulation protocol October 22nd, 2017

Creation of coherent states in molecules by incoherent electrons October 21st, 2017

Tools

Creation of coherent states in molecules by incoherent electrons October 21st, 2017

Bringing the atomic world into full color: Researchers turn atomic force microscope measurements into color images October 19th, 2017

Nanometrics Announces Preliminary Results for the Third Quarter of 2017: Quarterly Results Impacted by Delays in Revenue Recognition on Multiple Systems into Japan October 12th, 2017

Seeing the next dimension of computer chips: Researchers image perfectly smooth side-surfaces of 3-D silicon crystals with a scanning tunneling microscope, paving the way for smaller and faster computing devices October 11th, 2017

Appointments/Promotions/New hires/Resignations/Deaths

180 Degree Capital Corp. Appoints Investment Banking Veteran Parker Weil to Its Board of Directors August 2nd, 2017

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017



Premium Products


	Only the news you want to read! Learn More


	University Technology Transfer & Patents Learn More


	Full-service, expert consulting Learn More




	The latest news from around the world, FREE